843 Development and engineering of human sialidase for degradation of immunosuppressive sialoglycans to treat cancer

• Hui Xu,
• Li Peng,
• Abhishek Das,
• Lizhi Cao,
• Sujata Nerle,
• Robert LeBlanc,
• Sandip Shelke,
• Autumn Turner,
• Jenny Che,
• Zakir Siddiquee,
• Lihui Xu,
• Wayne Gatlin,
• James Broderick

Affiliations

Hui Xu

Big Data and Engineering Research Center, Beijing Children`s Hospital, Capital Medical University, National Center for Children`s Health, Beijing, China

Li Peng

Shanghai Center for Urban Environmental Meteorology, Shanghai, China

Abhishek Das

1Program in Cellular and Molecular Medicine, Boston Children’s Hospital

Lizhi Cao

Palleon Pharmaceuticals, Waltham, MA, USA

Sujata Nerle

Palleon Pharmaceuticals, Waltham, MA, USA

Robert LeBlanc

Palleon Pharmaceuticals, Waltham, MA, USA

Sandip Shelke

Palleon Pharmaceuticals, Waltham, MA, USA

Autumn Turner

Palleon Pharmaceuticals, Waltham, MA, USA

Jenny Che

Palleon Pharmaceuticals, Waltham, MA, USA

Zakir Siddiquee

Palleon Pharmaceuticals, Waltham, MA, USA

Lihui Xu

Palleon Pharmaceuticals, Waltham, MA, USA

Wayne Gatlin

Palleon Pharmaceuticals, Waltham, MA, USA

James Broderick

Palleon Pharmaceuticals, Waltham, MA, USA